Patents by Inventor Devi Sengupta

Devi Sengupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inducing an HIV-1-specific immune response using a chimpanzee adenovirus vector encoding an hivacat t-cell immunogen and TLR7 agonist
    Patent number: 12611453
    Abstract: The present disclosure describes methods, compositions, and kits related to the combination of a TLR7 modulating compound and an HIV vaccine. The combination can be used in a method of treating or preventing an HIV infection in a human.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: April 28, 2026
    Assignee: Gilead Sciences, Inc.
    Inventors: Romas Geleziunas, Devi Sengupta, Christian Brander, Beatriz Mothe Pujadas, Ian McGowan
  • COMBINATION OF A TLR7 MODULATING COMPOUND AND AN HIV VACCINE
    Publication number: 20220218711
    Abstract: The present disclosure describes methods, compositions, and kits related to the combination of a TLR7 modulating compound and an HIV vaccine. The combination can be used in a method of treating or preventing an HIV infection in a human.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 14, 2022
    Inventors: Romas Geleziunas, Devi Sengupta, Christian Brander, Beatriz Mothe Pujadas, Ian McGowan